These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 9102220

  • 1. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F, Fernández-Luna JL, Gajate C, Martín-Martín B, Benito A, Martínez-Dalmau R, Modolell M.
    Cancer Res; 1997 Apr 01; 57(7):1320-8. PubMed ID: 9102220
    [Abstract] [Full Text] [Related]

  • 2. Dissociation of the effects of the antitumour ether lipid ET-18-OCH3 on cytosolic calcium and on apoptosis.
    Alonso MT, Gajate C, Mollinedo F, Modolell M, Alvarez J, García-Sancho J.
    Br J Pharmacol; 1997 Aug 01; 121(7):1364-8. PubMed ID: 9257915
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
    Seewald MJ, Olsen RA, Sehgal I, Melder DC, Modest EJ, Powis G.
    Cancer Res; 1990 Aug 01; 50(15):4458-63. PubMed ID: 2369723
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, Modest EJ.
    Cancer Res; 1992 May 15; 52(10):2835-40. PubMed ID: 1316230
    [Abstract] [Full Text] [Related]

  • 5. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC, Wykle RL, Modest EJ, Daniel LW.
    Cancer Res; 1989 Aug 15; 49(16):4441-5. PubMed ID: 2743333
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
    Wagner BA, Buettner GR, Oberley LW, Burns CP.
    Cancer Res; 1998 Jul 01; 58(13):2809-16. PubMed ID: 9661895
    [Abstract] [Full Text] [Related]

  • 7. Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1 -one: protection by Bcl-2 and Bcl-X(L) and cell cycle arrest.
    Gajate C, Barasoain I, Andreu JM, Mollinedo F.
    Cancer Res; 2000 May 15; 60(10):2651-9. PubMed ID: 10825137
    [Abstract] [Full Text] [Related]

  • 8. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.
    Schmitt E, Sané AT, Steyaert A, Cimoli G, Bertrand R.
    Biochem Cell Biol; 1997 May 15; 75(4):301-14. PubMed ID: 9493953
    [Abstract] [Full Text] [Related]

  • 9. Mitochondrial-derived ROS in edelfosine-induced apoptosis in yeasts and tumor cells.
    Zhang H, Gajate C, Yu LP, Fang YX, Mollinedo F.
    Acta Pharmacol Sin; 2007 Jun 15; 28(6):888-94. PubMed ID: 17506948
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
    Marino-Albernas JR, Bittman R, Peters A, Mayhew E.
    J Med Chem; 1996 Aug 16; 39(17):3241-7. PubMed ID: 8765506
    [Abstract] [Full Text] [Related]

  • 11. Role of bcl-X(L) in the control of apoptosis in murine myeloma cells.
    Gauthier ER, Piché L, Lemieux G, Lemieux R.
    Cancer Res; 1996 Mar 15; 56(6):1451-6. PubMed ID: 8640839
    [Abstract] [Full Text] [Related]

  • 12. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
    Samadder P, Richards C, Bittman R, Bhullar RP, Arthur G.
    Anticancer Res; 2003 Mar 15; 23(3B):2291-5. PubMed ID: 12894505
    [Abstract] [Full Text] [Related]

  • 13. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization.
    Kosano H, Takatani O.
    Cancer Res; 1989 Jun 01; 49(11):2868-70. PubMed ID: 2785846
    [Abstract] [Full Text] [Related]

  • 14. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
    Samadder P, Arthur G.
    Cancer Res; 1999 Oct 01; 59(19):4808-15. PubMed ID: 10519389
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
    Berggren MI, Gallegos A, Dressler LA, Modest EJ, Powis G.
    Cancer Res; 1993 Sep 15; 53(18):4297-302. PubMed ID: 8395981
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM, Turchi JJ.
    Cancer Res; 1999 Jul 01; 59(13):3077-83. PubMed ID: 10397248
    [Abstract] [Full Text] [Related]

  • 17. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL.
    Rashmi R, Kumar S, Karunagaran D.
    Carcinogenesis; 2005 Apr 01; 26(4):713-23. PubMed ID: 15661804
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
    Fontana JA, Sun RJ, Rishi AK, Dawson MI, Ordónez JV, Zhang Y, Tschang SH, Bhalla K, Han Z, Wyche J, Poirer G, Sheikh MS, Shroot B, Reichert U.
    Oncol Res; 1998 Apr 01; 10(6):313-24. PubMed ID: 9848102
    [Abstract] [Full Text] [Related]

  • 19. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
    Lindenboim L, Yuan J, Stein R.
    Oncogene; 2000 Mar 30; 19(14):1783-93. PubMed ID: 10777212
    [Abstract] [Full Text] [Related]

  • 20. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
    Sawada M, Nakashima S, Banno Y, Yamakawa H, Takenaka K, Shinoda J, Nishimura Y, Sakai N, Nozawa Y.
    Oncogene; 2000 Jul 20; 19(31):3508-20. PubMed ID: 10918609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.